How should I manage a 47‑year‑old woman who is still menstruating but has menopausal symptoms, with progesterone 1.5 ng/mL, follicle‑stimulating hormone (FSH) 5.9 IU/L, luteinizing hormone (LH) 5.3 IU/L, estradiol 69 pg/mL, serum iron 46 µg/dL, ferritin 30 ng/mL, and normal thyroid function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Perimenopausal Symptoms with Low Iron Stores

This 47-year-old woman is in early perimenopause (not menopause) based on her hormone profile, and requires both iron repletion for her low ferritin and consideration of cyclic oral micronized progesterone for symptom management.

Hormonal Status Assessment

Your patient's laboratory values reveal she is in early perimenopause, not menopause:

  • FSH 5.9 IU/L and LH 5.3 IU/L are NOT elevated (menopause typically shows FSH >25-40 IU/L) 1
  • Estradiol 69 pg/mL is normal to slightly elevated for perimenopause 2
  • Progesterone 1.5 ng/mL is low, suggesting anovulation or luteal insufficiency 3

The paradox of perimenopause is that estradiol levels actually average 26% higher than normal due to disturbed brain-ovary feedback, while progesterone becomes insufficient or absent 3. Her symptoms likely stem from this hormonal imbalance—high, erratic estrogen with inadequate progesterone—rather than estrogen deficiency 2.

Iron Deficiency Management

Her iron studies show functional iron deficiency:

  • Ferritin 30 ng/mL (low-normal, suboptimal)
  • Serum iron 46 µg/dL (low)

For a premenopausal woman under age 50 with ongoing menses:

  • Screen for celiac disease with tissue transglutaminase antibodies (tTG) 4
  • Initiate oral iron supplementation immediately 4
  • GI investigation is NOT routinely indicated at age 47 unless she has GI symptoms, family history of colorectal cancer, or fails to respond to iron replacement 4
  • Menstrual blood loss is the presumed etiology given her age and menstruating status 4

Symptom Management Strategy

Oral micronized progesterone (OMP4) 300 mg at bedtime is the physiologically appropriate first-line therapy for symptomatic perimenopause 3:

Dosing Algorithm:

  • If still having regular cycles: Give cyclically on cycle days 14-27 (or 14 days on/14 days off) 3
  • If cycles irregular or late perimenopause: Consider daily dosing 3
  • If heavy menstrual bleeding present: Add ibuprofen 200 mg every 6 hours plus OMP4 on cycle days 4-28 3

Why Progesterone, Not Estrogen:

The evidence shows symptomatic perimenopausal women have higher estradiol and lower progesterone levels 3. Since progesterone and estradiol complement/counterbalance each other's tissue effects, replacing the deficient hormone (progesterone) addresses the root imbalance 3. OMP4 decreases vasomotor symptoms, improves sleep, treats premenstrual mastalgia, does not increase breast proliferation or cancer risk, increases bone formation, and has beneficial cardiovascular effects 3.

Important Caveats

Do NOT use standard menopausal hormone therapy (MHT) at this stage. The Endocrine Society guideline emphasizes MHT is for postmenopausal women, particularly those <60 years or <10 years from menopause 1. Your patient is still menstruating and perimenopausal—she needs progesterone replacement, not estrogen supplementation 3, 5.

Avoid oral contraceptives as well—these are inappropriate for perimenopause and represent overtreatment 3. The goal is physiologic hormone balance, not contraception or supraphysiologic hormone levels.

Monitor response: If symptoms persist after 2-3 months of cyclic progesterone, reassess hormone levels and consider whether she has transitioned to late perimenopause requiring daily dosing 3.

Follow-Up Parameters

  • Recheck ferritin in 3 months to confirm response to iron supplementation 4
  • Reassess symptoms after 2-3 cycles of progesterone therapy 3
  • If no improvement with iron and progesterone, investigate for celiac disease and other causes of malabsorption 4
  • Serial FSH measurements are NOT helpful during perimenopause due to wide fluctuations 5

References

1
Guideline

treatment of symptoms of the menopause: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

5
Research

The Menopause Transition: Signs, Symptoms, and Management Options.

The Journal of clinical endocrinology and metabolism, 2021

Related Questions

What is the appropriate management for a 48-year-old woman with perimenopausal symptoms who works two shifts?
What are the implications of a Luteinizing Hormone (LH) level of 5.2 milli-international units per milliliter (mIU/mL) in a 42-year-old female (F) experiencing perimenopause symptoms?
In a 43-year-old woman with progesterone <0.5 ng/mL, estradiol <30 pg/mL, luteinizing hormone ≈12 IU/L, follicle‑stimulating hormone ≈9 IU/L, total testosterone 23 ng/dL, free testosterone 2.9 pg/mL, and sex hormone‑binding globulin 82 nmol/L, what is the most likely diagnosis and what is the appropriate first‑line management?
Should menopausal hormone therapy improve low libido, hair loss, and pruritus in a 53-year-old perimenopausal African-American woman with a known endocrine disorder, last menstrual period one month ago after previously irregular cycles, and no vasomotor symptoms?
I am a 40‑year‑old woman with regular periods taking dehydroepiandrosterone (DHEA) and oral micronized progesterone for perimenopausal symptoms; do I need to add estrogen and how should progesterone be dosed for endometrial protection?
In a patient with extensive Pneumocystis jirovecii pneumonia who is HIV‑negative, what are the possible underlying causes and differential diagnoses?
In a patient presenting within two hours with left-sided weakness, normal vital signs, left hemiparesis, and imaging showing a right carotid artery dissection with an M1 middle cerebral artery occlusion, what is the next best step in management?
For a patient already on therapeutic anticoagulation, how should I initiate Eliquis (apixaban)?
What is the diagnostic algorithm for evaluating potential amiodarone‑induced thyroid disease?
In a hypertensive patient with an anterior wall myocardial infarction, a 2/6 systolic murmur, basal crackles, low urine output (~40 mL in 2 hours), palpable bilateral radial pulses, hemoglobin 10 g/dL, and creatinine 1.6 mg/dL, which laboratory test best predicts outcome: plasma B‑type natriuretic peptide (BNP), serum cardiac troponin, serum lactate, or venous blood gas from a central line?
What is the appropriate step‑down antibiotic regimen after piperacillin‑tazobactam for a patient with acute pancreatitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.